Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-08-06Clinical Trial Update: Cyclophosphamide, Autologous Lymphocytes, and Aldesleukin in Treating Patients With Metastatic Melanoma
The clinical trial investigating cyclophosphamide, autologous lymphocytes, and aldesleukin for metastatic melanoma is no longer available.
-
CLINICAL_TRIALS trial_result · 2010-08-05Clinical Trial Update: Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma [Phase 2]
Phase 2 efficacy study of TLN-232 in patients with recurring metastatic melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. [Phase 1]
Phase 1 trial assessing safety and immune response of MKC1106-PP in patients with advanced cancer, including ovarian cancer and melanoma; th…
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma. [Phase 1]
A Phase 1 trial evaluating MKC1106-MT in patients with melanoma reports safety data and immune responses from a multi-component immunotherap…
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Multiepitope Peptide Vaccination in Melanoma [Phase 2]
A Phase 2 clinical trial evaluating a multiepitope peptide vaccination for metastatic melanoma is ongoing, sponsored by Charité University i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors [Phase 2]
Phase II trial evaluating dendritic cell-based immunotherapy in combination with tumor-infiltrating lymphocytes for solid tumors including r…
-
CLINICAL_TRIALS trial_result · 2010-05-10Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]
Clinical trial update for a biological therapy in treating metastatic melanoma; the study completed in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2010-05-07Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
Phase 1 clinical trial evaluating a biological therapy for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Dendritic Cell Based Therapy of Malignant Melanoma [Phase 1, Phase 2]
A dendritic cell–based therapy for advanced melanoma has completed Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2010-04-15Clinical Trial Update: The Impact of Total Body Skin Examination on Skin Cancer Detection [NA]
A completed clinical trial evaluating the impact of total body skin examinations on the detection of skin cancers, including melanoma and ba…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Study of gp75 Vaccine in Patients With Stage III and IV Melanoma [Phase 1]
Phase 1 clinical trial of the gp75 vaccine in stage III/IV melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma [Phase 2]
A Phase 2 study evaluating ipilimumab monotherapy in previously treated unresectable stage III or IV melanoma has been completed.
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma [Phase 1]
Phase 1 clinical trial update assessing safety, tolerability, and preliminary efficacy of ALS-357 in patients with cutaneous metastatic mela…
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine [Phase 2]
Phase 2 monocentric pilot trial assessing metabolic activity of melanoma in vivo during treatment with sorafenib and dacarbazine; the study …
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating riluzole for surgically resectable stage III or stage IV melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma [Phase 1, Phase 2]
A phase 1/2 clinical trial of active specific intranodal immunotherapy using a recombinant vaccinia virus in locally advanced to metastatic …
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Evaluation of Pigmented Skin Lesions With MelaFind(R) System [Phase 3]
Phase 3 trial evaluating the MelaFind diagnostic system for pigmented skin lesions in melanoma completed with results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-10-21Clinical Trial Update: A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
A pilot study evaluated the use of intraoperative gamma camera imaging during sentinel lymph node biopsy in melanoma patients; the trial sta…
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients [Phase 1, Phase 2]
Phase 1/2 trial comparing peptide-pulsed dendritic cell vaccines with RNA-transfected dendritic cell vaccines in melanoma patients (stage II…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue
A completed clinical trial assessed intraoperative mapping of regional lymphatics draining the primary site of melanoma using the blue dye i…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Safety Study of CADI-05 in Patients With Advanced Stage Melanoma [Phase 1, Phase 2]
The safety study of CADI-05 in patients with advanced-stage melanoma has been terminated (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine [Phase 1]
A Phase 1 trial evaluated the safety and pharmacokinetics of a PARP inhibitor in combination with dacarbazine for melanoma, and the study is…
-
CLINICAL_TRIALS trial_result · 2009-05-11Clinical Trial Update: A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma [Phase 1, Phase 2]
A Phase 1/2 safety and efficacy study of intravenous 131I-TM601 in adults with malignant melanoma was conducted, but the trial was terminate…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating bevacizumab with dacarbazine and interferon-alfa for metastatic melanoma, which has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-31Clinical Trial Update: 131-I-TM-601 Study in Adults With Solid Tumors [Phase 1]
Phase 1 update on the radiopharmaceutical 131I-TM-601 in adults with solid tumors, including breast cancer, non-small cell lung cancer, mela…